Huons announced on the 11th that it has launched the electric smart insulin pen 'DIA:CONN P8' for the first time in Korea.


Huons' electric smart insulin pen 'Diacon P8'. <br>[Photo by Huons]

Huons' electric smart insulin pen 'Diacon P8'.
[Photo by Huons]

View original image

The DIA:CONN P8 is a reusable electric smart insulin pen linked with a continuous glucose monitor (CGM). It connects with DIA:CONN's diabetes management platform to provide real-time information on the patient's recent blood glucose levels and active insulin status, and helps prevent hypoglycemia by precisely injecting the necessary insulin using a bolus calculator.


Through the DIA:CONN Follow app, caregivers can monitor the patient's condition in real time. Medical staff can use DIA:CONN Care Web to understand the patient's insulin injection amount, blood glucose trends, patient blood glucose data, and statistical information, enabling comprehensive blood glucose management.


Huons aims to offer a new diabetes management option to patients undergoing multiple daily insulin injections (MDI) through the DIA:CONN P8. Additionally, it is expected to create synergy with the continuous glucose monitor 'Dexcom G6.'



Yoon Sang-bae, CEO of Huons, stated, "Through the DIA:CONN P8, we will provide an efficient diabetes management solution to patients receiving insulin therapy," and added, "We will do our best to establish it as a new treatment option for patients undergoing insulin therapy."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing